Aspen API has been awarded the EcoVadis Gold Medal in Jan 2026
24 Mar 2026 //
PRESS RELEASE
Strengthening the Oss pharma cluster through the arrival of Aspen
18 Dec 2025 //
PRESS RELEASE
Yes, #Estradiol is added to our list of approved CADIFA’s
30 Sep 2025 //
PRESS RELEASE
Gold Medal for Aspen API in EcoVadis Evaluation
31 Oct 2023 //
PRESS RELEASE
Get to know the Aspen API sales managers Interview with Janice
06 Jun 2023 //
PRESS RELEASE
Aspen Honored for Achievement in Product Innovation in 2023 Award
23 May 2023 //
PR NEWSWIRE
International Women’s Day, 2023. Embracing Diversity from within.
08 Mar 2023 //
PRESS RELEASE
Aspen Pharma Group has announced that it will receive 30M
13 Dec 2022 //
PRESS RELEASE
Aspen API created a revolutionary lean, clean & Peptide Synthesis
12 Dec 2022 //
PRESS RELEASE
Presentation Dirkjan van Zoelen and Martijn Bekker on sustainable API production
18 Nov 2022 //
PRESS RELEASE
It is almost time for Tides Europe again
10 Nov 2022 //
PRESS RELEASE
Join us at CPhI Frankfurt November 2022
30 Oct 2022 //
PRESS RELEASE
Aspen API mentioned as one of the top ten CMO Organizations
18 Oct 2022 //
PRESS RELEASE
We’re talking to Rani, Aspen API’s Global Product Manager
26 Sep 2022 //
PRESS RELEASE
The first Tuesday of September is Sustainable Tuesday
06 Sep 2022 //
PRESS RELEASE
Aspen Setback Illustrates Need For Africa To Build Up Vaccines Market
11 Aug 2022 //
PINK
Collaboration Aspen API and Dutch Kidney Foundation (Nierstichting Nederland)
12 Jul 2022 //
PRESS RELEASE
David Demailly, our API Commercial Director was interviewed by SpeakPharma
13 Jun 2022 //
PRESS RELEASE
From 14 to 25 March, Aspen API’s locations in the Netherlands, ‘De Geer’
01 Jun 2022 //
PRESS RELEASE
A lack of African J&J vaccine orders marks a `financial failure`
18 May 2022 //
FIERCEPHARMA
NMR system arrived at Analytical Sciences of Aspen OSS
09 May 2022 //
PRESS RELEASE
Aspen Oss awarded with gold medal by EcoVadis
29 Apr 2022 //
PRESS RELEASE
Debiopharm, Aspen Partner To Launch Prostate Cancer Drug Trelstar In S. Africa
01 Feb 2022 //
PRNEWSWIRE
White paper: Endocrine-disrupting pharmaceuticals in the environment
27 Jan 2022 //
PRESS RELEASE
White paper: Endocrine-disrupting pharmaceuticals in the environment
10 Dec 2021 //
PRESS RELEASE
S.Africa`s Aspen signs deal paving way for J&J COVID vaccine license
01 Dec 2021 //
REUTERS
South Africa`s Aspen in advanced talks over COVID-19 vaccine deal
29 Nov 2021 //
REUTERS
FCC awarded with gold medal by EcoVadis
01 Oct 2021 //
PRESS RELEASE
Aspen’s shares leap on two material unsolicited offers for API business
09 Sep 2021 //
IOL
Aspen receives `unsolicited` offers for active ingredients business
09 Sep 2021 //
NEWS24
S.Africa`s Aspen seeks licence for J&J COVID shot as EU shipments halted
02 Sep 2021 //
REUTERS
Aspen in talks with Johnson & Johnson to produce and market COVID-19 vaccine
02 Sep 2021 //
EXPRESSPHARMA
$200M from U.S. boosts Aspen`s vax production in South Africa
23 Jul 2021 //
FIERCEPHARMA
$200M from U.S. boosts Aspen`s vax production in South Africa
22 Jul 2021 //
FIERCEPHARMA
Aspen to partner with finance institutions to boost vaccine know-how
01 Jul 2021 //
REUTERS
J&J will export more COVID-19 vaccines to South Africa
14 Jun 2021 //
REUTERS
IFC and development groups to help fund vaccine production in Africa
01 Jun 2021 //
REUTERS
J&J, African Union in deal for up to 400 million COVID-19 shots
29 Mar 2021 //
REUTERS
South Africa`s Aspen could produce J&J COVID shots by end-March
07 Jan 2021 //
REUTERS
Aspen in R5bn value boost as it joins US giant to make Covid-19 vaccine
02 Nov 2020 //
IOL
Aspen could produce 10 million dexamethasone tablets within a month, says CEO
23 Jun 2020 //
THEJAKARTAPOST
South Africa`s Aspen could supply 10 million dexamethasone pills in COVID-19
23 Jun 2020 //
REUTERS
Pharma company director disqualified for competition law breaches
04 Jun 2020 //
GOVUK
Aspen focused on maintaining production during pandemic
15 May 2020 //
ENGINEERINGNEWS
South African drugmaker Aspen expects coronavirus impact
05 Mar 2020 //
REUTERS
UPDATE 2-South African drugmaker Aspen expects coronavirus impact
05 Mar 2020 //
CNBC
Sandoz completes acquisition of Aspen’s Japanese operations, strengthening
03 Feb 2020 //
PRESS RELEASE
GSK hit with EU Court ruling over ‘pay-for-delay’ drug case
01 Feb 2020 //
PHARMA TIMES
Tiofarma admits role in illegal agreement causing fludrocortisone price hikes
27 Jan 2020 //
EUROPEANPHARMACEUTICALREVIEW
CMA pins down Tiofarma for illegal market sharing
25 Jan 2020 //
PHARMA TIMES
Tiofarma admits role in illegal agreement causing fludrocortisone price hikes
24 Jan 2020 //
EUROPEANPHARMACEUTICALS
Aspen Gets Boost as Delayed Baby-Milk Deal Wins Approval
17 May 2019 //
BLOOMBERGQUINT
Aspen Pharmacare to build $235M production facility in South Africa
30 Oct 2018 //
FIERCE PHARMA
EDQM had granted a CEP for Leuprorelin
03 Oct 2017 //
PRESS RELEASE
Successful GMP inspection for Aspen Oss
24 Nov 2016 //
PRESS RELEASE
GSK unloads the last of its Aspen stake with $620M sale
29 Sep 2016 //
FIERCE PHARMA
GSK sells anaesthesia portfolio to Aspen
20 Sep 2016 //
BIOSPECTRUM
GSK sells non-core assets to Aspen
13 Sep 2016 //
PHARMATIMES
Endo scoops up Par Pharma for $8B to gain ground in injectables
19 May 2015 //
FIERCE PHARMA
EDQM granted CEP for tibolone
13 Mar 2014 //
PRESS RELEASE

Market Place
Sourcing Support